New therapeutic indications for botulinu
β
Carla Cordivari; V. Peter Misra; Santiago Catania; Andrew J. Lees
π
Article
π
2004
π
John Wiley and Sons
π
English
β 204 KB
The efficacy of botulinum toxin (BTX) without systemic effects has led to the rapid development of applications in neuromuscular disorders, hyperactivity of sudomotor cholinergic-mediated glandular function, and pain syndromes. The successful use of BTX in conditions with muscle overactivity, such a